High MSH6 further associated with the TCGA molecular subgroup of copy number high tumours (P < 0.001) and predicted reduced survival with a 5-year DSS of 84% in the high expression group and 94% in the low expression group (P < 0.001, Fig. 4a). Here, MSH6 is linked to neoplasm.